Most Common Adverse Events With JYNNEOS Are Nonserious
THURSDAY, Dec. 8, 2022 (HealthDay News) — The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to resear…
Learn MoreFDA Approves Bivalent COVID-19 Boosters for Children 6 Months and Older
THURSDAY, Dec. 8, 2022 (HealthDay News) — The updated bivalent COVID-19 boosters are now approved for use in children as young as 6 months of age, the U.S. Food and Drug Administration announced today.Children can receive either a Moderna or Pfizer-B…
Learn MorePaxlovid pronto no será gratuito para los estadounidenses
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — El antiviral Paxlovid ha evitado que las personas enfermen de gravedad y mueran por la COVID-19 desde que salió, sin ningún costo para ellas.Pero a mediados del próximo año, el gobierno de EE. UU. …
Learn MoreEl programa de seguridad de los alimentos de la FDA se debe renovar, según un panel
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — El programa de alimentos de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. está en una “agitación constante” y necesita un liderazgo más fuerte, señaló un panel el jueves.La Reagan-…
Learn MoreRSNA: Deductible Payments May Discourage Breast Imaging
THURSDAY, Dec. 8, 2022 (HealthDay News) — A deductible payment for follow-up breast imaging from abnormal screening discourages roughly one in five women from returning for diagnostic workup or causes them to skip screening altogether, according to a…
Learn MoreFDA OKs Bivalent COVID Boosters for Kids 6 Months and Older
THURSDAY, Dec. 8, 2022 (HealthDay News) — The updated bivalent COVID-19 boosters are now approved for use in children as young as 6 months of age, the U.S. Food and Drug Administration announced today.Children can receive either a Moderna or Pfizer-B…
Learn MoreAntibody Drug Boosts Survival for Type of Advanced Breast Cancer
THURSDAY, Dec. 8, 2022 (HealthDay News) — A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven’t responded to other treatments, according to a pair of clinical trials.The targeted antibod…
Learn MoreIs a Ban on Menthols Enough to Thwart Big Tobacco?
THURSDAY, Dec. 8, 2022 (HealthDay News) — A proposed U.S. federal ban on menthol cigarettes doesn’t go far enough and needs to include other menthol products, from pipe tobacco to cigarette tubes, researchers say. New evidence shows both the appeal a…
Learn MoreMore Americans Are Moving to Wildfire-Prone Areas
THURSDAY, Dec. 8, 2022 (HealthDay News) — Some Americans appear to be moving from areas with frequent hurricanes and heat waves to places threatened by wildfire and rising heat. They’re trading in the risk of one set of natural disasters for another …
Learn MoreCOVID-19 Vaccine Prevents Against Reinfection
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — Completing a primary COVID-19 vaccination series is associated with significant protection against reinfection among previously infected individuals, according to a study published online Nov. 22 in PLOS Med…
Learn More